We will explore how the explosion of biomedical data will require complex integration and analysis to better understand the molecular basis of phenotypes.

Open-source data is used across many industries, but it’s time we start to act upon the benefits it presents for medical research.

Personalized Medicine has the potential to change everything about the way that treatment is developed and researched and in analgesics, it could lead to a wave of new...

Around 20% of the US population1 experience chronic pain and 8% of US adults report ‘high-impact’ chronic pain2. Estimates suggest that other Western countries report...

Pain R&D forms the foundations for the entire pain management process, with these initial decisions key to whether pain treatments succeed or fail. The truth is,...

Late Breaking Poster Presentation - #TH408 TITLE: PainCLOUD® - A Novel in-silico Network Biology Methodology to Develop Personalized Analgesics®. PRESENTER: Mark J....

In this article, we will explore why pain research is so expensive, and how our B2B platform, Pain Cloud®, can help to reduce these costs, paving the way for a brighter...

Did you know that one in four people worldwide are suffering from chronic pain? Read on to find out how our B2B platform, Pain Cloud®, can help you improve your POS...